XML 15 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Operating activities:    
Net income (loss) $ (322,059) $ 146,180
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock-based compensation expense 988,857 814,060
Amortization of closing and earnout shares 386,756  
Amortization of intangible assets 149,200 0
Depreciation and amortization 108,764 107,700
Accretion and amortization on debt securities 43,621 98,312
Provision for bad debt   10,100
Changes in assets and liabilities:    
Accounts receivable (300,856) (572,520)
Other assets 55,031 136,760
Accounts payable 73,959 (355,962)
Accrued payroll and related taxes (825,856) (374,752)
Deferred revenue 727,698 950,712
Other liabilities (67,093) (38,624)
Net cash provided by operating activities 1,018,022 921,966
Investing activities:    
Purchases of investments (5,811,978) (2,826,867)
Sales and maturities of investments 6,395,000 6,931,088
Purchases of property and equipment (74,245) (13,393)
Net cash provided by investing activities 508,777 4,090,828
Financing activities:    
Proceeds from exercise of stock options, net 115,705 9,748
Principal payments on capital lease obligations (5,650) (5,061)
Net cash provided by financing activities 110,055 4,687
Foreign currency effect on cash and cash equivalents (35,587)  
Net increase in cash and cash equivalents 1,601,267 5,017,481
Cash and cash equivalents at beginning of period 2,752,638 7,766,590
Cash and cash equivalents at end of period 4,353,905 12,784,071
Supplemental disclosures of cash flow information:    
Cash paid for interest 601 1,191
Cash paid for income taxes 10,500 2,897
Supplemental disclosures of non-cash investing and financing activities:    
Unrealized holding loss on available-for-sale investments $ (20,287) $ (2,187)